multiple sclerosis Flashcards
multiple sclerosis
• A chronic demyelinating disease that affects the myelin sheath of neurons in the CNS
incidence of MS
Onset: between 20-40 years
Affects women 2x more than men
Affects more Whites
Prevalent in the northern latitudes
etiology of MS
Exact cause unknown
? Viral etiology which triggers immune-mediated demyelination (Epstein-Barr virus)
pathophysiology of MS
- The myelin sheath is essential for normal conduction of nerve impulses
- Plaques form along myelin sheath causing inflammation, edema, scarring and destruction
- Plaques may occur anywhere in white matter of CNS, but most commonly affects: optic nerves, cerebrum, cervical spinal cord
MS clinical patterns
Relapsing-remitting most common initial pattern
MS clinical manifestations
Weakness or paresthesias of one or more extremities (cerebrum)
Vision loss from optic neuritis
Incoordination (cerebellum)
Bladder dysfunction: frequency, loss of sensation, incontinence, retention, hyperreflexia
Constipation
Sexual dysfunction
Fatigue: common, often disabling
Spasticity
Emotional responses: depression, apathy, emotional instability
MS diagnostics
NO definitive test
Based on clinical presentations
MRI: to determine presence of MS plaques
CSF: cerebrospinal fluid for presence of oligoclonal banding (Oligodendrocytes are responsible for making myelin)
Evoked potentials of the optic pathways and auditory system to assess for slowed nerve conduction
MS management focuses on
Treatment of acute relapses
Treatment of disease management
Symptomatic Treatment
for an acute MS relapse
IV or Oral corticosteroids (Methylprednisolone)
MS symptomatic treatment
Bladder dysfunction: oxybutynin
Constipation: Metamucil, Dulcolax suppositories (Repeated stimulant use for constipation can cause dependence)
Spasticity: Baclofen (muscle relaxant)
Tremor: phenoorbital, propranolol
Fatigue: Amantadine (Symmetrel), Modafinil (Provigil)
Trigeminal Neuralgia: Dilantin (phenytoin), Amitriptyline
MS nursing diagnoses
Deficient Knowledge r/t new diagnosis of MS
Impaired Urinary Elimination r/t bladder dysfunction
Constipation r/t immobility and demyelination
Activity Intolerance r/t fatigue and muscle weakness
Impaired Physical Mobility r/t weakness, contracture, spasticity, and ataxia
Risk for Self-Care Deficit r/t muscle weakness
Situational Low Self Esteem r/t loss of independence and fear of disability
Altered Sensory Function r/t visual changes
MS impaired urinary elimination r/t blader dysfunction
Neurogenic bladder most common bladder dysfunction
Maintain fluids
Void q3hrs
For retention: Intermittent self-cath using clean technique
MS constipation r/t immobility and demyelination
High fiber diet Stool softeners Adequate fluids Avoid laxative, enema dependence Glycerin or digital stimulation to initiate evacuation
MS activity intolerance r/t fatigue and muscle weakness
Fatigue exacerbated by warm temperatures
Plan activities for peak energy level, usually in morning
Plan rest periods
MS impaired physical r/t weakness, contractors, spasticity, and ataxia
ROM bid to stretch spastic muscles water therapy (Flexor muscles are stronger than extensors)
Antispasmodics (Baclofen (Lioresal): provides synaptic inhibition of spinal reflexes)
Splints to help maintain position (Foot drop: severe plantar flexion, may need surgical intervention for Achilles)